ELTX

Elicio Therapeutics, Inc. - Common Stock (ELTX)

About Elicio Therapeutics, Inc. - Common Stock (ELTX)

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Details

Daily high

$2.02

Daily low

$1.91

Price at open

$1.92

52 Week High

$16.00

52 Week Low

$1.70

Market cap

49.7M

Dividend yield

Volume

484,464

Avg. volume

374,728

P/E ratio

-.89

Elicio Therapeutics, Inc. - Common Stock News